Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI commemorates World AIDS Day in a landmark year for HIV prevention

December 2, 2024

Long-acting PrEP offers tremendous hope for prevention, but a vaccine remains necessary to end HIV as a public health threat.

Read more

Scientific Publications

Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK

Read more

Podcasts

Meet the Scientist Episode 4: Dr. Vincent Muturi-Kioi on IAVI’s HIV vaccine development program

November 26, 2024

In this episode of Meet the Scientist, IAVI’s podcast series, we learn about why IAVI has more hope now than ever that we are on the right path to developing...
Read more

Scientific Publications

Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial

Read more

Scientific Publications

Healthcare use and sexually transmitted infections treatment-seeking: a mixed methods cross-sectional survey among hard-to-reach fishing communities of Lake Victoria, Uganda

Read more

Broadly neutralizing antibodies and their use in HIV research

Antibodies are natural proteins that the body makes that fight disease. Broadly neutralizing antibodies (bnAbs) are a special kind of antibody that is now being researched to see how they can play a role in HIV prevention.

Read more

IAVI Report

Drug-resistant microbes are on the march. Vaccines to the rescue?

November 21, 2024

Vaccines against deadly microbial pathogens could put a dent in antimicrobial resistance.

Read more

In The News

Tuberculosis – a global public health emergency

Zendal

November 20, 2024

Read more